Hybridoma Culture & Monoclonal Antibody Production — Serum Selection Guide
Hybridoma technology remains the foundation of monoclonal antibody discovery. Four of the ten best-selling antibody drugs originate from hybridoma-based discovery programmes, and the global therapeutic antibody market exceeded 267 billion USD in 2024. Every hybridoma laboratory requires serum as a core culture supplement — and the grade of serum used directly determines fusion efficiency, clonal stability, and antibody titre. This guide covers the complete hybridoma and mAb production workflow with specific SeamlessBio product recommendations for each stage.
Hybridoma Workflow — Serum Requirements at Each Stage
| Stage | Process Step | Recommended Product | Key Note |
|---|---|---|---|
| Immunisation | Host animal immunisation — mouse, rat, rabbit, goat | Species-matched serum for pre-immune titre baseline: Mouse Serum | Rat Serum | Rabbit Serum | Goat Serum |
Pre-immune serum from same species required as negative control for titre monitoring by ELISA |
| Fusion | B cell / myeloma cell fusion — PEG or electrofusion | FBS Ultra Low IgG <5 µg/mL — 10–20% in HAT selection medium | Low IgG reduces background in post-fusion ELISA screening. HAT selection medium requires high-quality serum for hypoxanthine/thymidine uptake efficiency. |
| HAT Selection | Selective culture of hybridoma clones in HAT medium | FBS Ultra Low IgG <5 µg/mL — 10–20% | Consistent lot quality critical — HAT selection efficiency varies with FBS lot. Batch reservation strongly recommended. |
| Screening | ELISA screening of hybridoma supernatants for target antibody | FBS Ultra Low IgG <5 µg/mL in culture + BSA Low Endotoxin as ELISA blocking agent | Bovine IgG in standard FBS creates ELISA background that masks low-titre positive clones. BSA Low Endotoxin as 1–3% blocking agent in ELISA development buffer. |
| Cloning | Limited dilution cloning or FACS single-cell sorting | FBS Ultra Low IgG <5 µg/mL — 20% for single-cell cloning support | Higher serum concentration supports single-cell recovery. Feeder cells (peritoneal macrophages) may be used — species-matched serum recommended. |
| Expansion | Scale-up of positive clones for antibody production | FBS Ultra Low IgG <5 µg/mL — 5–10% | Reduce serum concentration at expansion stage to lower bovine IgG load in supernatant before purification. |
| Production | Antibody production in static flasks, roller bottles, or bioreactor | FBS Ultra Low IgG <5 µg/mL — 2–5% or serum-free | Minimise serum at production stage — less bovine IgG co-purification on Protein A/G. Consider serum-free or low-serum transition for GMP-grade mAb production. |
| Purification | Protein A/G affinity chromatography, buffer exchange, formulation | BSA Low Endotoxin ≤5 EU/mg in formulation buffer | BSA as protein stabiliser in antibody formulation buffer — prevents mAb adsorption to container surfaces. Low Endotoxin grade essential. |
Why FBS Grade Matters — Standard FBS vs. Ultra Low IgG
| Parameter | Standard FBS | FBS Ultra Low IgG <5 µg/mL |
|---|---|---|
| Bovine IgG content | 200–800 µg/mL | <5 µg/mL — chromatographically depleted |
| ELISA screening background | High — bovine IgG cross-reacts with anti-mouse/anti-rabbit secondary antibodies | Minimal — background eliminated |
| Protein A/G purification | Bovine IgG co-purifies — reduces mAb purity | No bovine IgG co-purification |
| Clone detection sensitivity | Low-titre clones masked by background | Full detection sensitivity — no masking |
| Growth factors / albumin | Standard levels | Fully retained — depletion is IgG-specific |
| Cost | Reference | Higher — but eliminates downstream failures |
Animal Sera for Immunisation — Pre-Immune and Bleed Monitoring
Species-matched serum is required as a negative control at each stage of the immunisation programme — pre-immune baseline, mid-programme titre checks, and terminal bleed comparison. SeamlessBio supplies sera from all common laboratory animal species used in monoclonal antibody programmes.
| Species | Application in mAb Programme | Product |
|---|---|---|
| Mouse (BALB/c) | Most common hybridoma host — pre-immune serum for ELISA baseline. Normal mouse serum as negative control throughout. | Mouse Serum → |
| Rat | Rat hybridoma programmes — pre-immune serum control. Rat anti-mouse antibody production. | Rat Serum → |
| Rabbit | Rabbit B cell immortalisation (EBV or electrofusion). High-affinity antibody programmes. Pre-immune control. | Rabbit Serum → |
| Goat | Polyclonal antibody production. Pre-immune goat serum as blocking agent in immunoassays using goat-derived secondary antibodies. | Goat Serum → |
| Sheep | Sheep polyclonal programmes. Normal sheep serum as blocking agent. | Sheep Serum → |
| Guinea Pig | Complement source in CDC and complement fixation assays. Guinea pig complement is highly potent. | Guinea Pig Serum → |
BSA in Antibody Production — Key Applications
| Application | BSA Grade | Concentration | Function |
|---|---|---|---|
| ELISA blocking buffer | BSA Low Endotoxin ≤5 EU/mg | 1–3% in PBS-T | Blocks non-specific binding in ELISA plates — critical for hybridoma screening assay sensitivity |
| Antibody dilution buffer | BSA Low Endotoxin | 0.1–1% | Stabilises antibody during serial dilution — prevents adsorption to tube surfaces |
| Conjugation buffer | BSA Low Endotoxin or BSA Fatty Acid-Free | 0.1% | Protein stabiliser during HRP, biotin, or fluorophore conjugation reactions |
| Formulation buffer | BSA Low Endotoxin | 0.001–0.1% | Prevents mAb adsorption to vial surfaces — critical for low-concentration antibody storage |
| Immunoassay standard preparation | BSA Low Endotoxin or BSA pH 5.2 | 0.1–1% | Matrix matching for calibration standards — reduces non-specific binding in immunoassay standard curves |
Human Serum AB for Human Hybridoma and EBV Immortalisation
For human monoclonal antibody programmes using EBV immortalisation of human B cells or human hybridoma technology, human serum is required — not FBS. Human B cells and humanised cell lines require a species-matched matrix for optimal growth and antibody secretion.
| Application | Product | Why |
|---|---|---|
| EBV-immortalised human B cell culture | Human Serum AB Heat Inactivated — 10% | HI eliminates complement-mediated lysis of EBV-immortalised B cells. AB type prevents blood group-mediated agglutination. |
| Human hybridoma culture | Human Serum AB Heat Inactivated — 10–20% | Species-matched matrix for human × human hybridoma fusion products. Eliminates xenogenic stimulation from bovine components. |
| PBMC-based antibody secretion assays | Human Serum AB Heat Inactivated — 5–10% | Human matrix for human immune cell functional assays. HI prevents complement activation during PBMC culture. |
Antibody Production Service
For laboratories without in-house hybridoma capability, SeamlessBio offers an antibody production brokerage service — connecting you with validated European contract production partners for custom monoclonal and polyclonal antibody generation.
| Service | Details |
|---|---|
| Custom monoclonal antibody production | Mouse, rat, rabbit hybridoma programmes. Antigen design consultation, immunisation, fusion, screening, cloning, scale-up. |
| Custom polyclonal antibody production | Rabbit, goat, sheep, guinea pig. Multi-bleed programmes with titre monitoring. |
| Antibody characterisation | Isotyping, affinity determination, cross-reactivity testing. |
| Scale-up production | Ascites, roller bottle, bioreactor scale — milligram to gram quantities. |
For antibody production service enquiries: info@seamlessbio.de
Frequently Asked Questions
Why is FBS Ultra Low IgG required for hybridoma culture?
Standard FBS contains 200–800 µg/mL bovine IgG. When hybridoma supernatants are screened by ELISA using anti-mouse or anti-rabbit secondary antibodies, the secondary antibody cross-reacts with bovine IgG in the culture medium — creating a high background signal that masks low-titre positive clones. Additionally, bovine IgG co-purifies with the target mAb on Protein A/G affinity columns, reducing final antibody purity. FBS Ultra Low IgG <5 µg/mL eliminates both problems.
Can I use standard FBS for the immunisation stage?
The immunisation stage does not involve cell culture — it is an in vivo process. Standard FBS is not used for immunisation. What is required is species-matched pre-immune serum from the host animal as a negative ELISA control for titre monitoring throughout the immunisation programme.
What BSA grade for ELISA blocking in hybridoma screening?
BSA Low Endotoxin ≤5 EU/mg is the correct grade. High-endotoxin BSA can activate cells during blocking incubation steps and generate non-specific ELISA signal. For maximum assay sensitivity in hybridoma screening ELISAs, BSA Low Endotoxin at 1–3% in PBS-Tween blocking buffer is the standard approach.
Which serum for guinea pig complement in CDC assays?
Normal Guinea Pig Serum is the standard complement source for CDC and complement fixation assays. Guinea pig complement is highly active and broadly reactive — it is the conventional choice for CDC assays in hybridoma-derived anti-tumour mAb characterisation. SeamlessBio supplies Guinea Pig Serum on request.
Related Applications
| Application | Link |
|---|---|
| Cytotoxicity Assays (ADCC, CDC) | Cytotoxicity Assay Guide → |
| PBMC & Immunology | PBMC & Immunology Guide → |
| FBS Ultra Low IgG product page | FBS Ultra Low IgG → |
Technical enquiries, batch reservation, GMP documentation: info@seamlessbio.de | +49 851 37932226